Výsledky vyhledávání - "Veltman Joris D"

Akademický článek

COX-2 inhibition improves immunotherapy and is associated with decreased numbers of myeloid-derived suppressor cells in mesothelioma. Celecoxib influences MDSC function

Autor: Veltman Joris D, Lambers Margaretha EH, van Nimwegen Menno, Hendriks Rudi W, Hoogsteden Henk C, Aerts Joachim GJV, Hegmans Joost PJJ

Publikováno v: BMC Cancer, Vol 10, Iss 1, p 464 (2010)

Abstract Background Myeloid-derived suppressor cells (MDSC) are a heterogeneous population of immature cells that accumulates in tumour-bearing hosts. These cells are induced by tumour-derived factors (e.g. prostaglandins) and have a critical role in

Externí odkaz: https://doaj.org/article/efe0c4fefe8e411ba68ee18c2cffc665

Zobrazit plný text záznamu

Akademický článek

Predictive Value of Combined Positive Score and Tumor Proportion Score for Immunotherapy Response in Advanced NSCLC

Autor: Ulas, Ezgi B., Hashemi, Sayed M.S., Houda, Ilias, Kaynak, Adem, Veltman, Joris D., Fransen, Marieke F., Radonic, Teodora, Bahce, Idris

Publikováno v: In JTO Clinical and Research Reports September 2023 4(9)

Zobrazit plný text záznamu

Akademický článek

History of tuberculosis as an independent prognostic factor for lung cancer survival

Autor: Heuvers, Marlies E., Aerts, Joachim G.J.V., Hegmans, Joost P., Veltman, Joris D., Uitterlinden, André G., Ruiter, Rikje, Rodenburg, Eline M., Hofman, Albert, Bakker, Marleen, Hoogsteden, Henk C., Stricker, Bruno H., van Klaveren, Rob J.

Publikováno v: In Lung Cancer June 2012 76(3):452-456

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Akademický článek

Dynamics of methylated cell-free DNA in the urine of non-small cell lung cancer patients.

Autor: Bach, Sander, Wever, Birgit M.M., van de Wiel, Mark A., Veltman, Joris D., Hashemi, Sayed M.S., Kazemier, Geert, Bahce, Idris, Steenbergen, Renske D.M.

Publikováno v: Epigenetics; Oct2022, Vol. 17 Issue 10, p1057-1069, 13p

Zobrazit plný text záznamu

Comparison of myelotoxicity and nephrotoxicity between daily low-dose cisplatin with concurrent radiation and cyclic high-dose cisplatin in non-small cell lung cancer patients

Autor: Zazuli, Zulfan, Kos, Renate, Veltman, Joris D., Uyterlinde, Wilma, Longo, Cristina, Baas, Paul, Masereeuw, Rosalinde, Vijverberg, Susanne J.H., Maitland-van der Zee, Anke Hilse, Afd Pharmacology, Pharmacology, Pharmacoepidemiology and Clinical Pharmacology

Publikováno v: Frontiers in Pharmacology
Frontiers in Pharmacology, 11. FRONTIERS MEDIA SA
Frontiers in Pharmacology, 11. Frontiers Media S.A.
Frontiers in Pharmacology, Vol 11 (2020)
Frontiers in pharmacology, 11:975. Frontiers Media S.A.

Aim Antineoplastic effect of cisplatin, the first line treatment in non-small cell lung cancer (NSCLC), is hindered by its nephrotoxicity and myelotoxicity. Both low-dose and high-dose regimens are used in the management of NSCLC. The aim of this stu

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::748bb529c91f74fd412abc53b5771a2f
https://doi.org/10.3389/fphar.2020.00975